Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 561

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 561
---
 be recognized until Cara has fulfilled its obligations under the Original HCR Agreement (see “Royalty Purchase and Sale Agreement” above). As a result, there was no royalty revenue for the three and nine months ended September 30, 2024.

Clinical compound revenue

There was no clinical compound revenue for the three months ended September 30, 2024. Cara recognized clinical compound revenue of approximately $84,000 for the nine months ended September 30, 2024, and $66,000 and $165,000 for the three and nine months ended September 30, 2023, respectively, which were related to sales of clinical compound to Maruishi.

Other revenue

Cara recognized non-cash revenue of approximately $1.3 million and $2.9 million for the three and nine months ended September 30, 2024, which represent royalty payments earned in conjunction with ex-U.S. sales of KORSUVA/Kapruvia under Cara’s agreements with CSL Vifor and Maruishi, which were sold to HCR under the Original HCR Agreement. There was no non-cash revenue recognized for the three and nine months ended September 30, 2023.

<div align='center'>326</div>

TABLE OF CONTENTS

Cost of Goods Sold

| ​                  
 ​                  
 ​                  | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Three Months EndedSeptember 30, 
 2024                            
 Dollar amounts in thousands     |   |   |   | ​ | ​ | 2023 |   |       |   | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | ​        
 % change 
 ​        | ​ 
 ​ | ​     
 ​     | ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Nine Months EndedSeptember 30, 
 2024                           
 Dollar amounts in thousands    |   |     |   | ​ | ​ | 2023 |   |       |   | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | ​        
 % change 
 ​        | ​ 
 ​ | ​    
 ​    | ​ 
 ​ | ​ 
 ​ 
 ​ |
|:-------------------|:--|:--|:--------------------------------|:--|:--|:--|:--|:--|:-----|:--|------:|:--|:--|:--|:---------|:--|:------|:--|:--|:--|: